Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
This study is currently recruiting participants.
Study NCT00819910. Last updated on January 8, 2009.
Information provided by Brooke Army Medical Center
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 4 Hyperlipidemia
Normoglycemia
Additional conditions recognized in this trial
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Rosiglitazone
Placebo (Rosiglitazone)
Placebo (Fenofibrate)
Fenofibrate
Additional drug interventions recognized in this trial
Procetofen
More general drug interventions related to this trial
Antilipemic Agents
Antimetabolites
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Brooke Army Medical Center
GlaxoSmithKline
Back to top of Main Content